A new blood test that could help identify Alzheimer’s earlier from healthcare company Roche has received a Breakthrough Device Designation from the U.S. Food and Drug Administration. The test, branded “Elecsys” and under development with Eli Lilly and Company, can aid in identifying the likelihood of amyloid pathology in a person’s brain, according to Laura […]
Pharmaceutical giant Eli Lilly (NYSE: LLY) on Monday launched a late-stage clinical trial in long-term care facilities for its Covid-19 antibody treatment. The Phase 3 trial, dubbed BLAZE-2, is being conducted in partnership with the National Institute of Allergy and Infectious Diseases (NIAID), and will enroll up to 2,400 residents and staff at nursing homes […]
The Centers for Medicare and Medicaid Services has specified it will provide some coverage for a potential Alzheimer’s test, although not yet widespread. The test includes beta-amyloid imaging; a PET scan, drug administration and doctor’s interpretation, not yet proven sufficient to improve health outcomes for Medicare beneficiaries with dementia or neurodegenerative disease, CMS says. But there […]
